Barclays’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-174,042
| Closed | -$1.6M | – | 4235 |
|
2021
Q2 | $1.6M | Buy |
174,042
+142,896
| +459% | +$1.31M | ﹤0.01% | 1854 |
|
2021
Q1 | $155K | Buy |
31,146
+19,119
| +159% | +$95.1K | ﹤0.01% | 3221 |
|
2020
Q4 | $52K | Sell |
12,027
-5,182
| -30% | -$22.4K | ﹤0.01% | 3165 |
|
2020
Q3 | $74K | Sell |
17,209
-3,217
| -16% | -$13.8K | ﹤0.01% | 3138 |
|
2020
Q2 | $93K | Buy |
20,426
+8,145
| +66% | +$37.1K | ﹤0.01% | 3157 |
|
2020
Q1 | $49K | Sell |
12,281
-24,769
| -67% | -$98.8K | ﹤0.01% | 3113 |
|
2019
Q4 | $314K | Buy |
37,050
+18,538
| +100% | +$157K | ﹤0.01% | 2949 |
|
2019
Q3 | $127K | Sell |
18,512
-5,369
| -22% | -$36.8K | ﹤0.01% | 3281 |
|
2019
Q2 | $199K | Buy |
23,881
+11,426
| +92% | +$95.2K | ﹤0.01% | 3203 |
|
2019
Q1 | $114K | Buy |
12,455
+12,057
| +3,029% | +$110K | ﹤0.01% | 3282 |
|
2018
Q4 | $4K | Sell |
398
-11,982
| -97% | -$120K | ﹤0.01% | 3814 |
|
2018
Q3 | $173K | Buy |
12,380
+8,982
| +264% | +$126K | ﹤0.01% | 3147 |
|
2018
Q2 | $36K | Sell |
3,398
-1,879
| -36% | -$19.9K | ﹤0.01% | 3421 |
|
2018
Q1 | $45K | Buy |
5,277
+1,287
| +32% | +$11K | ﹤0.01% | 3549 |
|
2017
Q4 | $38K | Buy |
3,990
+3,406
| +583% | +$32.4K | ﹤0.01% | 3454 |
|
2017
Q3 | $5K | Sell |
584
-2,228
| -79% | -$19.1K | ﹤0.01% | 3676 |
|
2017
Q2 | $24K | Sell |
2,812
-11,808
| -81% | -$101K | ﹤0.01% | 3224 |
|
2017
Q1 | $103K | Buy |
+14,620
| New | +$103K | ﹤0.01% | 2822 |
|
2015
Q2 | – | Sell |
-316
| Closed | -$2K | – | 4263 |
|
2015
Q1 | $2K | Sell |
316
-536
| -63% | -$3.39K | ﹤0.01% | 3933 |
|
2014
Q4 | $6K | Sell |
852
-9,814
| -92% | -$69.1K | ﹤0.01% | 3910 |
|
2014
Q3 | $96K | Buy |
10,666
+10,258
| +2,514% | +$92.3K | ﹤0.01% | 2667 |
|
2014
Q2 | $7K | Buy |
408
+173
| +74% | +$2.97K | ﹤0.01% | 3810 |
|
2014
Q1 | $4K | Buy |
+235
| New | +$4K | ﹤0.01% | 4063 |
|